Bio B2B 〉 Selective Search Results
Your Selection Setting ：Biologics；
Selective Search Results :
Biotech Companies 17 record(s)；
GRAPE KING BIO LTD.
For 47 years, Grape King Bio has srived to be one of the top health food manufacturers in the biotechnology industry. Being an ISO22000/HACCP/NSF GMP certified manufacturer, we are able to guarantee the highest standards in product safety, quality and manufacturing. Together with our visionary and dedicated staff at Grape King Bio, we aim to take biotechnology to the next level.
EirGenix is a Biologic Drug Development Company, and a Contract Development and Manufacturing Organization (CDMO). Current pipelines involve seven products in development ranging from discovery to clinical, such as HER2 family biosimilars, antibody-drug conjugates (ADCs), and carrier protein for vaccine therapy.EirGenix provides high quality and cost-effective service, supporting our clients
TSH Biopharm Co., Ltd.
Chronic disease is one of the most important issues related to life expectancy and modern civilization. It is also the niche market TSH Biopharm devotes itself to; we focus on cardiovascular and autoimmune disease, and we contribute to patients, medical institutions and society constantly by developing patentable and high-barrier specialty drugs that have a pharmacoeconomics profile
CHO Pharma Inc.
CHO Pharma, founded in 2013, is a biopharmaceutical company mainly focused on the development and commercia-lization of innovative products based on the proprietary glycan engineering technologies. Together with our strategic partner, Academia Sinica in Taiwan, we strive for continuous innovation on glycan-based technology and are committ-ed to deliver best-in-class targeted and differentiated products
Panion & BF Biotech Inc.
IntroductionEstablished in 1976, Panion & BF Biotech (PBF) is a company specialized in the manufacturing of pharmaceutical products With its diligent effort to seek business transformation, upgrade and expansion over the past years, PBF is now a well-established international biopharmaceutical company specialized in diversified operations, including new drug development, drug manufacturing, cosmeceutical/nutraceuticals
Taiwan Advance Bio-Pharmaceutical Inc.
Invested by Taiwan Government--the Ministry of Economic Affairs--in 2000, Taiwan Advance Bio-Pharmaceutical Incorporation (TABP) is the first biotechnology company in Taiwan, specializing in the food and feed diagnostic kits. Till now TABP has over 60 product lines, whose range cover most common used chemical compounds such as ractopamine and tetracycline, and a 90% domestic market share. The key features
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Our extensive experience with liposome science allows us to combine speed of onset and duration of benefit and to improve API
SOFIVA GENOMICS is an assembly of authoritative physicians and expert consultants in maternal-fetal medicine, cancer medicine, medical genetics, and clinical medicine. We aspire to act as both clinical physicians and research scientists and closely join fundamental medical research and clinical diagnosis together using translational medicine so as serve our mission and value in medical genetics.Our
Microbio Co., Ltd.
MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group's approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded
Fountain Biopharma, Inc.
Fountain Biopharma, a subsidiary company of Microbio group, founded in December 2010 in Taiwan, focus on development of therapeutic monoclonal antibdoies for cancer and immunological conditions, aiming to meet unmet medical needs with innovation. Fountain has instituted several antibody library, high yield production cell line, upstream/downstream process development technology, analytical methods
Henlix Biotech Co., Ltd
Henlix Biotech Inc., an innovative biopharmaceutical company, was co-founded by two American biopharmaceutical veterans, Dr. Scott Liu and Dr. Weidong Jiang in October 2010, in Taiwan and expanded its research site in the San Francisco Bay Area. The company specializes in the discovery and development of innovative monoclonal antibody therapeutics, bi-specific antibodies and antibody drug
Vedan Biotechnology corp.
Our parent company, Vedan Enterprise Corp., has been dedicated to researching and developing fermentation technology since 1954. Determined to achieve perfection and willing to take an innovative approach, Vedan has established itself as the leader in the Taiwanese amino acid industry. As a world-class producer of Glutamic acid, Vedan seeks beneficial applications of microorganisms for
Sinphar Pharmaceutical Co., Ltd.
Upholding its philosophy, “public's health is Sinphar's ideal” Sinphar Group has accompanied the public for almost 40 years. All these time, the company has always embraced its focus on “life, health, and technology” in developing therapeutic drugs, health care foods, and medical beauty products to provide the public with the best service for protecting their health
PharmaEngine, Inc. is a biopharmaceutical company established in February 2003 with funding from TTY Biopharm, National Development Fund and Taiwanese venture capital. We are a networked pharma company that operates according to a combination of "No Research Development Only (NRDO)" model and "Networked Pharma" model. Our company is led by Dr. C. Grace Yeh, and supported
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
Value Creation – Adimmune StyleFounded in 1965Ticker: 4142 TT278 Full Time EmployeesDedicated research, development and manufacturing of human vaccine and aseptic PFS FillingRevenue of NT$290mn/156 mn in 2015/1H2016Market cap of US$171 mn (as of 2016/10/24)§ Headquarters: Taichung, Taiwan§ cGMP Vaccine Facility:Certificate: EU, China, Korea and Taiwan cGMP obtained. Capacity:
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology